GlassScriptPhysician profile
Marcus D Mazur
NPI 1104141647
$17,421.54
in general payments reported to CMS, 2019-2025
12 companies · $1,272 in 2025
The $1,272 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,568 · 2020: $160 · 2021: $323 · 2022: $3,953 · 2023: $5,296 · 2024: $3,849 · 2025: $1,272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,470 · Food and Beverage: $2,947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,469.89 |
| Food and Beverage | $2,947.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,986.34 | 2021-2025 | Cd Horizon Spinal System, Mazor X System, Stealthstation S8 Platform |
| Globus Medical, INC. | $4,230.27 | 2022-2025 | Quartex, Caliber, Excelsius Gps |
| Cerapedics INC. | $1,860.91 | 2020-2022 | |
| Synthes Gmbh | $1,678.15 | 2024 | |
| Stryker Corporation | $1,123.53 | 2019-2025 | Universal Neuro 3, 1688, Target |
| Medtronic USA, INC. | $1,078.10 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $947.51 | 2019 | |
| Nuvasive, INC. | $752.55 | 2019-2023 | Alif |
| Zimvie INC. | $257.50 | 2023-2024 | |
| Highridge Medical LLC | $238.29 | 2024 | Spine-None |
| Alphatec Spine, INC | $154.93 | 2024 | |
| Si-Bone, INC. | $113.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Mazur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.